In our current study, we found that inhibition of CRM1 activity by KPT-185 prevented p53 from exiting the nucleus, resulting in nuclear p53 accumulation and stabilization in p53 wide type NSCLC A549 cells. Here, TP53 is linked to non-small cell lung carcinoma.